1 September 2014
An analysis of the financial implications of achieving earlier diagnosis of colorectal, lung and ovarian cancer
Evoke Incisive Health was commissioned by Cancer Research UK to analyse the financial consequences of earlier diagnosis in planning cancer services. Our findings show that there is a clear financial dividend from earlier diagnosis, as well as a compelling case for improving cancer survival.
If you like how we think, what we offer, and our mission to make health more human™, check out our open roles.
Inizio is a strategic partner for companies in health and life sciences that connects a full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services across the lifecycle of a drug.Learn more